1-2 of 2
Clinical Trials and Observations/Investigator-Initiated Trials
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A phase 1 study of interleukin-15 in combination with mogamulizumab in relapsed and refractory T-cell malignancies

Clinical Trials & Observations
Max J. Gordon, Sigrid Dubois, Milos D. Miljkovic, Samuel Ng, Bonita Bryant, Rahul Lakhotia, Christopher Melani, Stefania Pittaluga, Kevin Conlon, Thomas Waldmann, Louis M. Staudt, Wyndham H. Wilson, Mark Roschewski
Journal: Blood Neoplasia
Blood Neoplasia (2025) 2 (1): 100054.
https://doi.org/10.1016/j.bneo.2024.100054
Published: 2025
Journal Articles

JAK1/2 inhibitor ruxolitinib for the treatment of systemic chronic active Epstein-Barr virus disease: a phase 2 study

Clinical Trials & Observations
Yu Uemura, Masahide Yamamoto, Masataka Ishimura, Hirokazu Kanegane, Akihisa Sawada, Akihiro Hirakawa, Ken-Ichi Imadome, Mayumi Yoshimori, Masashi Nagata, Kouhei Yamamoto, Norio Shimizu, Ryuji Koike, Ayako Arai
Journal: Blood Neoplasia
Blood Neoplasia (2025) 2 (1): 100053.
https://doi.org/10.1016/j.bneo.2024.100053
Published: 2025
Includes: Supplemental data